Curcumin, a potential therapeutic candidate for retinal diseases (Q38082487)

28 August 2017

Curcumin, a potential therapeutic candidate for retinal diseases (English)

1 reference

28 August 2017

0 references

Lei-Lei Wang

1

1 reference

28 August 2017

Yue Sun

series ordinal

2

1 reference

28 August 2017

Kun Huang

series ordinal

3

1 reference

28 August 2017

Ling Zheng

series ordinal

4

1 reference

28 August 2017

18 February 2013

1 reference

Molecular Nutrition and Food Research

28 August 2017

1 reference

28 August 2017

57

1 reference

28 August 2017

9

1 reference

28 August 2017

1557-1568

1 reference

Turmeric--chemistry, technology, and quality

28 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Pharmacology of Curcuma longa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Cardioprotective effects of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

The protective role of curcumin in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Neuroprotective effects of curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Visual map development: bidirectional signaling, bifunctional guidance molecules, and competition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Development of the retina and optic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Development of the retinal vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

21 January 2018

The targets of curcumin.

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin and the cellular stress response in free radical-related diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin reduces oxidative and nitrative DNA damage through balancing of oxidant-antioxidant status in hamsters infected with Opisthorchis viverrini

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Heme oxygenase in the regulation of vascular biology: from molecular mechanisms to therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Lysine acetylation in obesity, diabetes and metabolic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Nutrition, epigenetics, and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

CBP and p300: HATs for different occasions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Receptive fields and functional architecture in the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Neuroprotection in glaucoma - Is there a future role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

The role of oxidative stress in the pathogenesis of age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Prevalence of diabetic retinopathy in the United States, 2005-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

The pathogenesis of early retinal changes of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Neural degeneration in the retina of the streptozotocin-induced type 1 diabetes model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Effects of curcumin on retinal oxidative stress and inflammation in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Oxidative stress and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Elevated histone acetylations in Müller cells contribute to inflammation: a novel inhibitory effect of minocycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Anti-angiogenesis drugs in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Vascular complications and diabetes: current therapies and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-alpha and IFN-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin modulates SDF-1alpha/CXCR4-induced migration of human retinal endothelial cells (HRECs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Proliferative vitreoretinopathy: pathobiology and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Inhibitory effect of epigallocatechin gallate (EGCG), resveratrol, and curcumin on proliferation of human retinal pigment epithelial cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Retinal ganglion cells and neuroprotection for glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

The molecular basis of retinal ganglion cell death in glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Intraocular pressure as a risk factor for visual field loss in pseudoexfoliative and in primary open-angle glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Retinal ischemia: mechanisms of damage and potential therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin inhibits neuronal and vascular degeneration in retina after ischemia and reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Mitochondrial fusion and fission in cell life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin treatment protects rat retinal neurons against excitotoxicity: effect on N-methyl-D: -aspartate-induced intracellular Ca(2+) increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin protects against NMDA-induced toxicity: a possible role for NR2A subunit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Characterization of a transformed rat retinal ganglion cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin attenuates staurosporine-mediated death of retinal ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Molecular pathology of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Pegaptanib for neovascular age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

VEGF Trap-Eye for the treatment of neovascular age-related macular degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

The role of inflammation in the pathogenesis of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin protects retinal cells from light-and oxidant stress-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

A point mutation of the rhodopsin gene in one form of retinitis pigmentosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Rescue of photoreceptor degeneration by curcumin in transgenic rats with P23H rhodopsin mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Cellular mechanisms of tumour suppression by the retinoblastoma gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Ral GTPases contribute to regulation of cyclin D1 through activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Effect of curcumin on miRNA expression in human Y79 retinoblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Efficacy of curcumin in the management of chronic anterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Glaucoma associated with uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Dose escalation of a curcuminoid formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

Matrix and the retinal pigment epithelium in proliferative retinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMNFR.201200718

21 January 2018

Identifiers

DOI

10.1002/MNFR.201200718

1 reference

28 August 2017

1 reference